Urinary markers for prostate cancer
โ Scribed by Michelle R. Downes; Jennifer C. Byrne; Stephen R. Pennington; Michael J. Dunn; John M. Fitzpatrick; R. William G. Watson
- Book ID
- 109052948
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 85 KB
- Volume
- 99
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract We have previously shown that endoglin (CD105) is upregulated in prostatic fluid of men with large volume prostate cancer. We chose to assess endoglin levels in urine and serum from men with prostate cancer or at increased risk for the disease: Urine samples were collected after digital
## BACKGROUND. The incidence and mortality of prostate cancer are increasing at alarming rates, partially due to an aging population. Early detection of prostate cancer, using clinically sensitive procedures and/or tumor markers (e.g., prostate-specific antigen [PSA]), is of prime importance. Howe